News FDA advisers split on new kidney cancer use for Pfizer's Sut... Committee could not decide if Sutent can be used after the removal of a cancerous kidney.
News Pfizer sues J&J, alleging it blocked access to Remicade bios... J&J used anticompetitive tactics to prevent use of cheaper Inflectra
Views & Analysis Pharma 2022: big pharma will remain a constant Pharma 2022: big pharma to maintain its position, ready to pounce on any newcomer that shows promise.
Partner Content Partner Content Have you seen the agenda for Social Media in Pharma? Updates on Social Media in Pharma
News NICE approval would let Novartis' Kisqali steal a march on I... Novartis' breast cancer treatment Kisqali has gained final EU approval today - and the company is confident it can follow this with a swift reimbursement recommendation from the UK's NICE.<
News UK offers meningitis jab to young people after outbreak The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
